Savene® (dexrazoxane) use in clinical practice

Abstract

Anthracycline extravasation (ACEV) is a rare but potentially devastating event which can result in severe injuries including ulceration and necrosis, slow-healing lesions, serious joint damage and permanent disfigurement. It can delay further scheduled chemotherapy and affect cancer treatment outcome. Savene® (dexrazoxane) is the only approved antidote for… (More)
DOI: 10.1007/s00520-012-1382-2

3 Figures and Tables

Topics

  • Presentations referencing similar topics